(Q40005047)

16 September 2017

title

Effect of extracellular ATP on the growth of hormone-refractory prostate cancer in vivo (English)

1 reference

16 September 2017

1 reference

5

Geoffrey Burnstock

1 reference

16 September 2017

Majid Shabbir

1

1 reference

16 September 2017

Cecil Thompson

series ordinal

2

1 reference

16 September 2017

Michael Jarmulowiczc

series ordinal

3

1 reference

16 September 2017

Dimitri Mikhailidis

series ordinal

4

1 reference

16 September 2017

language of work or name

1 reference

5 March 2008

1 reference

16 September 2017

1 reference

16 September 2017

volume

102

1 reference

16 September 2017

issue

1

1 reference

16 September 2017

page(s)

108-112

1 reference

P2-purinergic receptor agonists inhibit the growth of androgen-independent prostate carcinoma cells

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07578.X

Effects of extracellular nucleotides and nucleosides on prostate carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07578.X

Orthotopic implantation of human prostate cancer cell lines: a clinically relevant animal model for metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07578.X

21 January 2018

P2 receptors and cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07578.X

Phase I trial of extracellular adenosine 5'-triphosphate in patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07578.X

Phase II study of intravenous adenosine 5'-triphosphate in patients with previously untreated stage IIIB and stage IV non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07578.X

Randomized clinical trial of adenosine 5′-triphosphate on tumor growth and survival in advanced lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07578.X

Isolation of a human prostate carcinoma cell line (DU 145)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07578.X

Enhanced Tumor Growth of Both Primary and Established Human and Murine Tumor Cells in Athymic Mice After Coinjection With Matrigel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07578.X

Calcitriol (1,25-dihydroxycholecalciferol) potentiates activity of mitoxantrone/dexamethasone in an androgen independent prostate cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07578.X

Anticancer activities of adenine nucleotides in mice are mediated through expansion of erythrocyte ATP pools.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07578.X

Pharmacokinetics of intravenous ATP in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07578.X

Randomized clinical trial of adenosine 5'-triphosphate in patients with advanced non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07578.X

10.1111/J.1464-410X.2008.07578.X

21 January 2018

Identifiers

DOI

1 reference

16 September 2017

1 reference